![World Cancer medicine on X: "Our livers have been compared to a chemical factory. In humans, liver disease is common. It is possible to treat liver disease and #thrombocytopenia with the tablet World Cancer medicine on X: "Our livers have been compared to a chemical factory. In humans, liver disease is common. It is possible to treat liver disease and #thrombocytopenia with the tablet](https://pbs.twimg.com/media/F3wzTaSaYAMh709.jpg:large)
World Cancer medicine on X: "Our livers have been compared to a chemical factory. In humans, liver disease is common. It is possible to treat liver disease and #thrombocytopenia with the tablet
![Announcement of listing on the NHI drug price standard and marketing of Doptelet® Tablet 20 mg in Japan | 2023 | News | Asahi Kasei Announcement of listing on the NHI drug price standard and marketing of Doptelet® Tablet 20 mg in Japan | 2023 | News | Asahi Kasei](https://www.asahi-kasei.com/news/2023/p33q4i000000004i-img/e230524_2_01.jpg)
Announcement of listing on the NHI drug price standard and marketing of Doptelet® Tablet 20 mg in Japan | 2023 | News | Asahi Kasei
Dawn Pharmaceticals Ltd. X પર: "#avatrombopag for patients with #chronicliver disease & #thrombocytopenia @BuscandoMedicin https://t.co/wBkUJt0JkY" / X
![These highlights do not include all the information needed to use DOPTELET safely and effectively. See full prescribing information for DOPTELET. DOPTELET ® (avatrombopag ) tablets, for oral use Initial U.S. Approval: 2018 These highlights do not include all the information needed to use DOPTELET safely and effectively. See full prescribing information for DOPTELET. DOPTELET ® (avatrombopag ) tablets, for oral use Initial U.S. Approval: 2018](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=doptelet-02.jpg&id=714268)